News

Gene therapy experts and advocates warning of the sector’s many challenges found a receptive audience in FDA leadership at a ...
Bionova Scientific opened its plasmid DNA production and development facility on May 29 in an effort to provide gene and cell ...
Cardinal Health's growth faces challenges from tariff risks, regulatory uncertainties, and competitive pressures. Learn more ...
Mice treated with the therapy had better cognitive function and similar patterns of gene expression to healthy models of the same age.
In a roundtable event on Thursday, HHS Secretary Robert F. Kennedy Jr. said his office will work to eliminate barriers that ...
Brainstorm tapped Minaris to manufacture NurOwn for its upcoming Phase 3b clinical trial testing the treatment for ALS.
Leaders from the world of cell and gene therapy shared their personal stories and policy recommendations in an extraordinary roundtable conducted by the FDA in front of its recently-appointed top ...
As favor in the general market swings away from cell therapy, Immatics’ CEO is choosing to focus on what he can control: ...
Victoria Gray is the first person in the world to receive CRISPR,  a gene-editing therapy for sickle cell disease created by ...
By reprogramming brain cells, a new gene therapy approach for Alzheimer's developed by UC San Diego researchers could address ...
While heritable human genome editing is banned in the United States, across Europe and much of the world, the technology ...
Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure ...